How the Gut Microbiome Is Rewriting the Future of Preventive Medicine

Approximately 38 trillion microorganisms inhabit the human gut, and their combined genetic material is 150 times greater than the human genome. The gut microbiome, once regarded as merely a "digestive aid," has since the 2010s been revealed in study after study to influence immune regulation, mental health, metabolic diseases, and even cancer risk. The future of preventive medicine begins in the gut.

The Gut Is the "Second Brain" and the Body's Largest Immune Organ

Approximately 90% of the body's serotonin -- the neurotransmitter that regulates mood and sleep -- is produced in the gut. While serotonin itself does not cross the blood-brain barrier, short-chain fatty acids and tryptophan metabolites produced by gut bacteria directly influence brain function via the vagus nerve. The elucidation of this "gut-brain axis" is attracting attention as a novel therapeutic approach for depression and anxiety disorders.

At the same time, approximately 70% of the immune system is concentrated in the gut-associated lymphoid tissue (GALT). Gut bacteria are essential for the maturation and training of immune cells, and a decline in their diversity correlates with increases in autoimmune diseases and allergies. The recognition that "the gut is the body's largest immune organ" is no longer metaphorical -- it is medical fact.

Diversity Is the Key to Health: Discoveries from the American Gut Project

The American Gut Project, led by Professor Rob Knight at the University of California San Diego (UCSD), collected 15,096 samples from 11,336 participants, making it the world's largest citizen-science microbiome study. The analysis published in mSystems in 2018 yielded groundbreaking insights into the relationship between the gut environment and diet.

The most significant finding was that "people who consume more than 30 different types of plants per week have significantly greater gut microbiome diversity than those who consume 10 or fewer." In the high-diversity group, beneficial bacteria that produce short-chain fatty acids were more abundant, while antibiotic resistance genes were reduced. Crucially, this effect was attributable not to any specific "superfood" but to dietary "diversity itself."

Diet Trumps Genetics: The PREDICT Study

The PREDICT study, led by Professor Tim Spector of King's College London, has fundamentally shifted the microbiome research paradigm. The results of PREDICT 1 (1,103 participants), published in Nature Medicine in 2020, demonstrated that the composition of the gut microbiome is more strongly associated with dietary patterns than with genetic factors. In other words, the gut environment is rewritable not by the genes you were born with, but by daily eating habits.

In 2024, a follow-up to the PREDICT study (21,561 participants) published in Nature Microbiology revealed precise correspondences between specific dietary patterns and gut bacterial species. The ZOE app developed by Professor Spector and colleagues, drawing on gut microbiome data from approximately 35,000 individuals, is advancing the practical implementation of personalized nutrition -- dietary recommendations optimized for each individual's gut environment.

The Japanese Gut Microbiome: A Unique Evolutionary Path

The Japanese gut microbiome possesses characteristics that are globally unique. Research by Professor Masahira Hattori of Waseda University, which compared gut microbiomes across 12 countries, found that approximately 90% of Japanese individuals harbor bacteria carrying enzymes (porphyranases) capable of breaking down seaweed such as nori and wakame. In other countries, this proportion is only about 15%. This is evidence that thousands of years of seaweed-eating culture have driven the evolution of gut bacteria.

RIKEN (the Institute of Physical and Chemical Research) has also produced important findings. In 2023, researchers elucidated the mechanism by which gut bacteria directly contribute to insulin resistance (a precursor to diabetes), and in 2025, they discovered that specific gut bacteria promote the worsening of multiple sclerosis. These findings suggest that controlling the gut microbiome could lead to the prevention and treatment of chronic diseases.

The Future of Microbiome Medicine

Gut microbiome research is providing individualized, precise answers to the universal question of "what should we eat?" As the PREDICT study demonstrated, blood sugar responses to the same food vary dramatically between individuals, and the primary driver of this variation is the composition of the gut microbiome.

Personalized nutrition -- dietary optimization based on an individual's gut microbiome profile -- represents the next frontier in preventive medicine. From treatment to prevention, from one-size-fits-all dietary guidance to individualized optimization. The science of the gut microbiome is quietly but steadily driving a fundamental paradigm shift in medicine.

Back to STORIES